Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
ohm20's Profile
Displaying 5651-5700 of 6050 result(s).
CYDY CytoDyn Inc
11/08/2019 1:53:55 PM
The discount would be the wholesale
CYDY CytoDyn Inc
11/08/2019 1:24:07 PM
We potentially have 273,000 patient (2)
CYDY CytoDyn Inc
11/07/2019 11:33:37 PM
The "ghost" was correct, I forgot r
CYDY CytoDyn Inc
11/07/2019 9:05:37 PM
The road to profitability I decided (1)
CYDY CytoDyn Inc
11/07/2019 2:22:28 PM
2003 pre-clinical Met-CCL5 https://
CYDY CytoDyn Inc
11/07/2019 8:44:54 AM
prior art, just like the Prostagene
CYDY CytoDyn Inc
11/07/2019 4:38:00 AM
I didn't realize Grip it was a supe
CYDY CytoDyn Inc
11/06/2019 6:31:28 PM
Thank you for the consideration. So
CYDY CytoDyn Inc
11/06/2019 6:07:21 PM
First, I assume he meant email. But (1)
CYDY CytoDyn Inc
11/06/2019 4:08:01 PM
Can you elaborate on that? Is it 5
CYDY CytoDyn Inc
11/06/2019 1:23:51 PM
That explains why all my posts have
CYDY CytoDyn Inc
11/06/2019 1:22:31 PM
I have ample opportunity to hit the (1)
CYDY CytoDyn Inc
11/04/2019 10:43:00 AM
The efficacy vastly improved with 5
CYDY CytoDyn Inc
11/04/2019 5:56:54 AM
She should bring in Hercule Poirot (1)
CYDY CytoDyn Inc
11/04/2019 3:12:39 AM
That this was omitted is very telli (2)
CYDY CytoDyn Inc
11/02/2019 10:28:08 PM
I understand where you're trying to
CYDY CytoDyn Inc
11/02/2019 10:25:00 PM
another is running a razor thin edg (2)
CYDY CytoDyn Inc
11/02/2019 12:58:12 PM
NP does seem to be inducing bipolar
CYDY CytoDyn Inc
11/02/2019 11:20:39 AM
Leronlimab and graft vs cancer effe
CYDY CytoDyn Inc
11/01/2019 5:59:09 PM
Since the potential commercializati
CYDY CytoDyn Inc
10/31/2019 12:55:58 PM
Hepatitis is on my list and I keep
CYDY CytoDyn Inc
10/31/2019 11:29:12 AM
Leronlimab, CCR5 and Tuberculosis h (1)
CYDY CytoDyn Inc
10/31/2019 11:26:27 AM
Leronlimab, CCR5 and COPD, Emphysem (1)
CYDY CytoDyn Inc
10/31/2019 11:18:31 AM
Just looked up their drug, it's MOA (2)
CYDY CytoDyn Inc
10/31/2019 12:13:08 AM
Why Syneos doesn't make sense to me (1)
CYDY CytoDyn Inc
10/30/2019 11:00:06 AM
Once we move on from OTC, hopefully (1)
CYDY CytoDyn Inc
10/30/2019 10:41:54 AM
A "theoretical" question. Why would (2)
CYDY CytoDyn Inc
10/30/2019 8:33:58 AM
Hunted down this paper, one of the (1)
CYDY CytoDyn Inc
10/29/2019 5:19:15 AM
They wouldn't need to do a revamp f
CYDY CytoDyn Inc
10/29/2019 3:19:02 AM
It looks like they're doing a major (1)
CYDY CytoDyn Inc
10/27/2019 4:58:20 PM
TRDING DISTORTING THE FACTS AS USUA (2)
CYDY CytoDyn Inc
10/27/2019 9:14:17 AM
What neither of them explained is t (1)
CYDY CytoDyn Inc
10/27/2019 7:09:20 AM
ach du lieber!!!
CYDY CytoDyn Inc
10/25/2019 10:07:02 AM
It's posted. :) (1)
CYDY CytoDyn Inc
10/25/2019 9:41:53 AM
Everything in this article is accur (2)
CYDY CytoDyn Inc
10/25/2019 7:15:48 AM
So... why on earth aren't they tumb (1)
CYDY CytoDyn Inc
10/25/2019 6:59:31 AM
Doing a quick look at the deal Gala (1)
CYDY CytoDyn Inc
10/25/2019 5:11:54 AM
No idea why they didn't take CYDY o (2)
CYDY CytoDyn Inc
10/24/2019 5:10:25 PM
First T-cells are activated , they (4)
CYDY CytoDyn Inc
10/24/2019 1:08:46 PM
The last update Nader said the end
CYDY CytoDyn Inc
10/24/2019 12:51:53 PM
I have faith in the company. I don' (4)
CYDY CytoDyn Inc
10/24/2019 12:39:25 PM
Are you sure the news isn't that Cy (3)
CYDY CytoDyn Inc
10/24/2019 8:57:25 AM
An email I sent to Dr. Pourhassan - (6)
CYDY CytoDyn Inc
10/23/2019 10:21:11 AM
Maybe the Iranians kidnapped his Mo
CYDY CytoDyn Inc
10/23/2019 10:14:28 AM
If this deal closes then What exact
CYDY CytoDyn Inc
10/23/2019 4:20:18 AM
The Lawman has been beating that dr (5)
CYDY CytoDyn Inc
10/23/2019 4:12:02 AM
Do you guys not want the deal to ge
CYDY CytoDyn Inc
10/22/2019 9:53:00 AM
And I was hoping this deal would de
CYDY CytoDyn Inc
10/22/2019 5:55:30 AM
Why are you here? Apparently masoch (1)
CYDY CytoDyn Inc
10/20/2019 5:02:21 PM
Deal already done with lower tier p (3)
Go to page:
  • << First
  • < Previous
  • 113
  • 114
  • Next >

Recent Articles

  • BW Opal FPSO Achieves First Gas, Enhancing Energy Production
  • The Urgent AI Race: Insights from Buck Sexton on Global Power
  • Tandem Diabetes Care Faces Legal Investigation: What You Should Know
  • Investors of Sable Offshore Corp. Encouraged to Act on SOC Claims
  • Jasper Therapeutics Faces Potential Securities Fraud Actions
  • Shaquille O'Neal's Surprising Investment in Google: A Fortune Gained
  • Concerns Grow Over Institutional Integrity Amid Political Turbulence
  • Understanding Quantum Threats: The Reality of Q-Day Unfolding
  • Unlocking Success: Charlie Munger's Timeless Work Principles
  • Lockheed Martin Investors: Join Securities Fraud Class Action Today
  • Tech Entrepreneur Transforms Wealth Into Philanthropy for Good
  • The Hiring Crisis for Gen Z: Understanding Key Economic Factors
  • Teen Hacking Ring Linked to Massive Extortion Scheme Unveiled
  • Investors Retain $7.7 Trillion in Money-Market Funds Amid Shifts
  • UREVO's Innovative Ecosystem Set to Transform Wellness Market
  • Elon Musk Clarifies xAI's Current Funding Status Amid Talks
  • Sable Offshore Corp. Investors: Don't Miss Your Class Action Rights
  • Apple's iPhone 17 Pro: A Game Changer in Premium Smartphones
  • SiBionics Revolutionizes Diabetes Management with CGM Innovations
  • Unlocking Career Happiness: Dan Ives' Passionate Insights
  • YourGroups Offers Unique Opportunities for Aspiring Leaders
  • Refreshing the Cobalt Trade: DRC's Innovative Export Changes
  • Investors Urged to Act on SelectQuote, Inc. Securities Case
  • Rising Government Shutdown Odds: Impacts on Investors and Firms
  • Fluor Corporation Faces Class Action: A Chance for Investors
  • Continuing the Vision: Legacy of Charlie Kirk Lives On
  • Lantheus Holdings Faces Securities Fraud Class Action Opportunity
  • Investors Can Take Legal Action in LifeMD Securities Case Soon
  • Investors Urged to Act: Nutex Health Class Action Deadline Nears
  • Clearing the Path: How US Regulations Could Propel Bitcoin
  • Embracing Diversity: Celebrating the Power of Hispanic Communities
  • Essential Steps to Consider Before Rolling Over Your 401(k)
  • Exploring the Transformative Power of Equine Therapy in Senior Care
  • Important Deadline Approaching for Lockheed Martin Investors
  • Essential Seasonal Guidance for Lakefront Property Buyers
  • Global AI Race: Buck Sexton Highlights America's Future Stakes
  • Tech Breakthroughs and Market Movements: Insights and Highlights
  • Amaury Pierron Achieves Victory at 2025 UCI Downhill Cup
  • Taliban Stands Firm Against Trump's Demands Over Bagram Base
  • Investing Insights: Stocks to Keep on Your Radar
  • Investigation of Class Action Claims for Charter Communications
  • Investigation Announced for Fiserv Investors Over Potential Losses
  • Lantheus Faces Legal Scrutiny: Investor Options Explained
  • Apple's iPhone 17 Launch, Meta Glasses, And AI Partnerships
  • Max Stock Limited Reveals Increased Shareholdings by Director
  • BYOMA's Innovative Blemish Solutions to Empower Skincare Users
  • Unlocking Skyward Innovation: Lockheed Martin's Vectis System
  • Lead Investors in Savara Inc. Pivotal Lawsuit for SEC Violations
  • Nutex Health Faces Serious Legal Challenges: Updates Inside
  • Investigation into Quantum Corporation Investor Claims Alert
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site